European stocks were mixed as investors weighed positive corporate earnings reports against concerns over rising COVID-19 cases. Sanofi announced its acquisition of U.S. biotech company Dynavax for $1.9 billion, expanding its vaccine portfolio. France strongly criticized the U.S. decision to ban travelers from Europe due to the Delta variant, calling it discriminatory and unjustified.

Read more at Investing.com: European stocks mixed, Sanofi buys Dynavax; France condemns U.S. visa ban